Substituted piperazine compounds and their use as fatty acid oxidation inhibitors

Details for Australian Patent Application No. 2008202958 (hide)

Owner CV Therapeutics, Inc.

Inventors Zablocki, Jeff; Shenk, Kevin; Elzein, Elfaith; Palle, Venkata; Ibrahim, Prabha; Rehder, Kenneth

Agent Freehills

Pub. Number AU-A-2008202958

Parent 2002322527

Filing date 3 July 2008

Wipo publication date 31 July 2008

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 263/57 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 277/64 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 July 2008 Complete Application Filed

31 July 2008 Application Open to Public Inspection

  Published as AU-A-2008202958

22 October 2009 Alteration of Name

  The name of the applicant has been altered to Gilead Palo Alto, Inc. Amendments

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202959-A garment

2008202957-Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders